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consequences in the extra-gastric regions. These consequences have been studied at length and can include
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testing for the diagnosis of H. pylori. Complete analysis of each article was performed to determine the most
relevant information regarding this topic. Article inclusion criteria included all relevant articles discussing the
adult population in the English language, published after 1995, that assisted the author in the determination of
the most appropriate test for a dyspeptic patient. Exclusion criteria were articles published before 1995 and
ones that discussed patients under the age of 18.
RESULTS: Four studies were found to meet the inclusion and exclusion criteria as well as stating clear and
precise data concerning the diagnostic tests needing to be examined.
CONCLUSION: For accurate results when a patient does not need an endoscopy or refuses such an invasive
procedure, urea breath testing is the best choice for the diagnosis of H. pylori. Other diagnostic tests such as
serology and stool antigen testing has been shown to either have a low accuracy rate or too many variables that
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Abstract   
 
INTRODUCTION:  Helicobacter Pylori is a common bacteria found in the stomach that 
can cause ulcers and more rarely gastric cancer.  There are multiple diagnostic tests that 
are currently available to detect this microorganism possibly making it difficult for 
providers to choose the most accurate or inexpensive test.  It is important to diagnosis H. 
pylori in symptomatic patients due to the potential of eliciting a series of pathologic 
consequences in the extra-gastric regions.  These consequences have been studied at 
length and can include cardiovascular and autoimmune disorders as well as certain 
digestive disorders such as liver disease.  METHODS: There are five diagnostic tests 
reviewed in this study including urea breath test, stool antigen assay, rapid urease test, 
serology and histology.  An exhaustive literature search was performed using multiple 
search databases including Medline, CINAHL, PubMed and Evidence Based Medicine 
Review Multifile. Literature from the past 15 years was reviewed and evaluated to 
determine the most accurate and cost effective testing for the diagnosis of H. pylori. 
Complete analysis of each article was performed to determine the most relevant 
information regarding this topic.  Article inclusion criteria included all relevant articles 
discussing the adult population in the English language, published after 1995, that 
assisted the author in the determination of the most appropriate test for a dyspeptic 
patient.  Exclusion criteria were articles published before 1995 and ones that discussed 
patients under the age of 18. RESULTS:  Four studies were found to meet the inclusion 
and exclusion criteria as well as stating clear and precise data concerning the diagnostic 
tests needing to be examined.  
CONCLUSION:  For accurate results when a patient does not need an endoscopy or 
refuses such an invasive procedure, urea breath testing is the best choice for the diagnosis 
of H. pylori.  Other diagnostic tests such as serology and stool antigen testing has been 
shown to either have a low accuracy rate or too many variables that can affect the 
outcome of the test.  KEYWORDS:  peptic ulcer, Helicobacter pylori, eradication, test, 
diagnosis, serology, histology, urea breath test, stool antigen, rapid urease.  .  
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In Patients with Peptic Ulcer Disease, What Is the Most 
Accurate Diagnostic Test to Determine the Presence of 
Helicobacter pylori prior to Treatment? 
 
Introduction 
 Abdominal pain is one of the most common chief complaints a patient will give 
his/her provider.  This complaint can be caused by a multitude of etiologies, however the 
most common is infection.  Helicobacter pylori is a bacteria that resides in the stomach 
and duodenum which affects more than 50% of the human population making it one of 
the more widespread pathogens.1 This bacterium has been associated with the 
development of peptic ulcer disease, adenocarcinoma of the gastric lining and mucosa 
associated lymphoid tissue (MALT) lymphoma.1  It is important to diagnosis H. pylori in 
symptomatic patients due to the potential of eliciting a series of pathologic consequences 
in the extra-gastric regions.  These consequences have been studied at length and can 
include cardiovascular and autoimmune disorders as well as certain digestive disorders 
such as liver disease. 1  
 Helicobacter pylori is a spiral shaped, slow growing gram negative bacterium.  
Biochemically characterized as catalase, oxidase and urease positive, this organism 
appears to require urease for its survival and colonization. Urease is produced in 
abundance which makes up more than 5% of the organism’s total protein weight. Urease 
produced by this bacteria is clinically important because it forms the basis for several 
invasive and noninvasive tests to diagnose infection. 2 
 The most common chronic bacterial infection in humans derives from the 
Helicobacter pylori bacterium.  Humans have been infected with H. pylori since they first 
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migrated from Africa around 58,000 years ago according to studies that have performed 
genetic testing. Demonstrated worldwide and in individuals of all ages, H. pylori 
infection is more frequent at early ages in developing countries compared to 
industrialized nations. Gastroduodenal disease may or may not occur once a host acquires 
this bacterium and is subsequently infected. 3 It remains unknown exactly how and why a 
gastrointestinal disturbance is initiated or by which route infection occurs.  Either 
fecal/oral or oral/oral exposure seems the most likely cause of person-to-person 
transmission. In developing countries, contaminated water supplies possibly serve as a 
source of these bacteria. Children who regularly swim in rivers, pools, drink stream water 
or eat uncooked vegetables are more likely to be infected. Person-to-person transmission 
is supported by the fact that infected individuals are more likely to have  same household 
family members that are already infected. 4 
Multiple combinations of medications have been evaluated for the treatment of 
Helicobacter pylori, however the optimal therapy has not yet been defined. The treatment 
that is selected must be effective, however it is important to consider cost, side effects 
and ease of administration.  5  In as many as 20 percent of patients fail eradication therapy 
for H. pylori after the first attempt. 6  A provider must have accurate and easily accessible 
diagnostic testing in order to successfully test for this organism and retest after treatment 
is complete to confirm the eradication. 
Both invasive and noninvasive forms of testing exist for the diagnosis of H. pylori 
depending on the need for esophagogastroduodenoscopy (EGD).   Diagnostics can also 
be either direct and indirect testing .  Direct diagnosis can be from a culture or biopsy. 
Indirect diagnoses is from an antibody or antigen response or by the verification of the 
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presence of urease.  Cost, availability, clinical situation, population, pretest probability of 
infection and factors such as the use of proton pump inhibitors and antibiotics will affect 
the choice of test and may influence certain test results.   The American College of 
Gastroenterology (ACG) proposed the most recent guidelines for diagnoising H. pylori in 
2007.  The guidelines are as follows: only if the clinician plans to offer treatment for 
positive results should testing be performed; patients with active peptic ulcer disease, a 
past history of documented peptic ulcer or gastric MALT lymphoma should be tested; the 
test and treat if positive approach is a proven management for patients with 
uninvestigated dyspepsia who are under the age of 55 years and have no bleeding, 
anemia, early satiety, unexplained weight loss, progressive dysphagia, odynophagia, 
recurrent vomiting, family history of GI cancer or previous esophagogastric malignancy. 
The provider must decide which test to use in which circumstance based upon whether a 
patient requires evaluation with EGD and their understanding of the strengths, 
weaknesses and costs of the tests being performed. 7   
There are five diagnostic tests that will be reviewed in this study. The urea breath 
test (UBT) is based upon the hydrolysis of urea by H. pylori to produce CO2 and 
ammonia. A labeled carbon isotope is given by mouth which makes H. pylori release 
CO2 which can be detected in breath samples. Two UBTs have been approved by the 
Federal Drug Administration (FDA).  Both the non-radioactive 13C test and the 
radioactive 14C test can be performed in about 20 minutes. Most providers prefer the 
13C test because it does not use a radioactive isotope.  The stool antigen assay was 
developed with the discovery of the presence of H. pylori in the stool of infected patients. 
The primary diagnosis of H. pylori can be made by a commercially available enzyme 
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immunoassay which is considered a reasonable method. The rapid urease test (RUT) uses 
specialized urea membrane kits that have been designed specifically to give a result 
within one hour. Antisecretory medications and antibiotics often affect these results. With 
these rapid urease tests, biopsy specimens are squeezed between a reagent strip with a pH 
indicator and a pad containing urea.  Enzyme-linked immunosorbent assay (ELISA) 
technology is used for laboratory based serologic testing to detect Immunoglobulin G 
(IgG) antibodies.  This technique is inexpensive, noninvasive and well suited to primary 
care practice.   Histology testing is performed using gastric biopsy which can be helpful 
in making the primary diagnosis of an H. pylori infection. This type of testing provides 
additional information regarding the detection of gastritis and the presence of intestinal 
metaplasia and mucosa-associated lymphoid tissue (MALT).  Laboratory based serologic 
testing from blood using ELISA to detect IgG antibodies is another test performed, however has 
had some low accuracy rates. 
Methods 
 An exhaustive literature search was performed using multiple search databases 
including Medline, CINAHL, PubMed and Evidence Based Medicine Review Multifile. 
Specific keywords were used in performing this search such as peptic ulcer, Helicobacter 
pylori, eradication, test, diagnosis, serology, histology, urea breath test, stool antigen, 
rapid urease.  Literature from the past 15 years was reviewed and evaluated to determine 
the most accurate and cost effective testing for the diagnosis of H. pylori. Complete 
analysis of each article was performed to determine the most relevant information 
regarding this topic.  Article inclusion criteria included all relevant articles discussing the 
adult population in the English language, published after 1995, that assisted the author in 
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the determination of the most appropriate test for a dyspeptic patient.  Exclusion criteria 
were articles published before 1995 and ones that discussed patients under the age of 18.  
 
Results 
A total of four articles were published between 1995 and 2009 that pertained to 
the diagnostic tests that are being compared and that fit my inclusion and exclusion 
criteria. (See Table 1)  
 Calvet et al. performed a prospective study which evaluated two 
noninvasive tests, the commercial infrared based UBT and the commercially available 
stool antigen test.  They also evaluated biopsy based tests which included a histological 
exam and a rapid urease test.  In the Calvet study, they considered a patient to be infected 
when at least two diagnostic test results were positive.  A total of 199 patients with 
dyspepsia were enrolled after confirmation that they had never been treated for 
Helicobacter pylori infection at a previous visit.  Rates for positive tests were similar 
(54%) for the rapid urease test, histopathological examination and the stool antigen test. 
However the rate for positive results for the UBT was 75% which was associated with a 
very low specificity (60%).  After reconfiguring this data with a new delta cutoff value, 
the sensitivities and specificities for the UBT were 95% and 100% respectively.  For the 
rapid urease test the sensitivity and specificity were 94% and 99% respectively, the 
histological exam 90% and 93% respectively, for the stool test were 90% and 93% 
respectively, and for the UBT 90% and 90% respectively. Calvet concluded that the 
histological examination and RUT remain the “uncontested gold standard” for the 
diagnoses of H. pylori infection.  They also concluded that the UBT could produce a high 
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rate of false positive result and lead to unnecessary treatment and associated costs with 
the current cutoff value. 8 
 Pacheco et al. assessed the diagnostic value of the most common clinical 
tests to detect H. pylori infection with the polymerase chain reaction (PCR).  They 
extracted serum and gastric biopsies from 106 dyspeptic patients.  The biopsies were 
examined histologically for rapid urease activity and PCR amplification of a urea gene 
segment of H. pylori.  Positive results were found for the serology, histology, rapid 
urease and PCR which were 56%, 86%, 64%, and 85% respectively. Most of the 
dyspeptic patients were found to have gastritis.  Compared to the PCR, the sensitivity and 
specificity for the serology was 55% and 38% respectively, 86% and 13% for the 
histology respectively and 70% and 69% for urease respectively.  They concluded that 
combining histology and urease for the diagnosis of infection showed no advantage over 
using the rapid urease test alone.  Due to this fact according to Pacheco, histology should 
no longer be considered a gold standard for the diagnosis of H. pylori infection.  The first 
option for a noninvasive diagnostic should be the urea breath test.  Highly specific and 
sensitive molecular diagnostic methods should be used to examine specimens if an 
invasive procedure is justified for diagnosis. 9 
 Thijs et al. assessed the accuracy of six diagnostic tests commonly used to 
identify H. pylori infection.  They prospectively studied 105 outpatients without using 
any specific test as a gold standard.  The patients underwent an EGD study which showed 
that 62 of them had no significant abnormalities, 28 had gastroesophogeal reflux disease, 
19 had peptic ulcers, on with erosive gastritis and one with atrophic gastritis. Some 
patients had more than one diagnosis.  Biopsies were taken from the antrum and were 
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used for culture, PCR, histological examination, and rapid urease test.  Also performed 
were serology using ELISA and C urea breath test.  The patients were considered 
infected when two or more tests were positive, no matter the symptoms. Sensitivity and 
specificity were as follows; culture, 98% and 100%; PCR, 97% and 100%; histological 
exam of the antrum, 96% and 98.8%; histological exam of the antrum plus the corpus; 
98.4% and 98.8%; rapid urease test 90% and 100%; C urea breath test, 100% and 100%; 
and serological examination, 98.4% and 88.4% (95% in patients who had not been 
previously infected treated for H. pylori. They concluded that all antral biopsy based tests 
and the C urea breath test were accurate for the diagnosis of H. pylori infection.  
Sampling error occurs, but is a minor importance. They state that the lower specificity of 
serological test may be due to previous treatment of H. pylori. 10 
Nishikawa et al. performed a prospective study evaluating two branded rapid 
urease tests before and after eradication treatment for Helicobacter pylori. The aim of the 
study was to examine the accuracy of these specific tests and compare it to the accuracy 
with histology, culture and 13C-urea breath test as a gold standard.  They studied two 
specific RUT, the Helicocheck and the PyloriTek. A total of 278 patients were examined, 
however they split the group into before treatment and after treatment groups.  This study 
will focus on the accuracy of the tests that were performed on the 115 patients examined 
prior to eradication. Eight biopsy specimens were taken from both the antrum and the 
body of the subject for histology, culture and two rapid urease tests.  The Helicobacter 
pylori infection was assessed by the combination of histology, culture and 13 C urea 
breath tests. These subjects were defined in their endoscopic diagnoses.  There were 46 
with gastric ulcers, 23 with duodenal ulcers, 7 with gastroduodenal ulcers, 24 with 
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gastritis and 15 with other diagnoses.  It was found that the patients with these diagnoses 
can have a predominate presence of intestinal metaplasia in the antrum where biopsies 
were taken. This would make it difficult for H. pylori to colonize due to the loss of H. 
pylori specific receptor structures on the epithelium and active secretion of IgA from 
metaplastic mucosa.  Due to this fact, additional biopsies were performed from the gastric 
body which would significantly improve the sensitivity.  The overall sensitivity, 
specificity and positive and negative predictive values of the Helicocheck before 
eradication were 91%, 100%, 100% and 62.5% respectively; the PyloriTek had values of 
92%, 100%, 100%, and 65.2% respectively. Both of these tests have “equally satisfactory 
overall sensitivity before eradication treatment.”  It was determined that biopsies from the 
gastric body had a significantly higher sensitivity than the antral biopsies. There was no 
mention of sensitivities or specificities for the “gold standard” tests such as histology, 
culture or UBT, except for a sensitivity of 92.1% for the UBT.  11 
Discussion 
  The primary goal of this study was to identify accurate evidence from recent 
medical literature discussing diagnostic tests for the identification of Helicobacter pylori 
infection. The variability of the tests included in each article may have a skewing effect 
to determine the best diagnostic test available. More studies are needed comparing all of 
the main tests to determine a more accurate gold standard.  The articles available either 
do not state a gold standard to compare against or the “gold standard” that they state is 
not consistent with other studies.  The American College of Gastroenterology does not 
recommend a gold standard diagnostic test.  A gold standard across the board for medical 
providers would make diagnosis such a common infection easier and in the long run more 
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cost effective for patients. Currently many factors account for the choosing of a specific 
diagnostic test for H. pylori.  Cost, accuracy, availability, bleeding risk, former treatment, 
severity of symptoms and need for endoscopy.   
 Calvet’s study evaluated four commonly used diagnostic tests to determine the 
presence of H. pylori, the urea breath test, stool antigen test, histological exam, and the 
rapid urease test.  The determination of a positive H. pylori patient was made when two 
of the tests became positive. Thijs chose a similar method in determining if the study 
participant was indeed positive for the bacteria. The UBT resulted in a very low 
specificity of 60% which led them to changing the cutoff value.  After this change the 
specificity and sensitivity improved dramatically.  Not including the UBT, the highest 
specificity and sensitivity values were concluded were with the rapid urease test of 94% 
and 99%.  Calvet’s study made it clear that if the patient was going to go in for an 
endoscopy that a rapid urease test should be the test chosen based on its accuracy and 
speed.   
 Pacheco’s study assessed gastric biopsies and serum and then compared them to 
PCR.   PCR is the best diagnostic test, but is expensive and time consuming so it is not a 
common diagnostic test used. The study used the biopsies to determine rapid urease 
activity and PCR amplification.  After comparing the results, it was determined that 
histology should no longer be considered the gold standard and may consider the rapid 
urease test to replace it.  However a RUT must be completed only after an endoscopy and 
biopsy which are both invasive. The study determined that the most accurate noninvasive 
test is the urea breath test, however they did not perform or calculate any urea breath tests 
on its subjects.  
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 Thijs’s study examined six diagnostic tests commonly used to diagnose H. pylori, 
the largest amount of test found in the literature search.  This article chose no gold 
standard to compare with its results.  The tests that were included are PCR, histology, 
rapid urease, serology and urea breath test.  Surprisingly this study calculated the 
sensitivity and specificity of the UBT to be 100% and 100%, both higher than culture and 
PCR.  Serology was an poor choice for diagnosis due to its potential for false negatives.  
 The Nishikawa study compared two rapid urease tests with the combination of 
histology, culture and a urea breath test as a gold standard.  Both the RUTs that were 
performed resulted in similar sensitivities and specificities. When compared with these 
values from the other studies, it was close in value except when compared with the 
Pacheco study which gave much lower values.   
Conclusion 
 Based on literature review, rapid urease testing is the best choice for the diagnosis 
of H. pylori when an endoscopy is needed.  For accurate results when a patient does not 
need an endoscopy or refuses such an invasive procedure, urea breath testing is the best 
choice for the diagnosis of H. pylori.  Other diagnostic tests such as serology and stool 
antigen testing has been shown to either have a low accuracy rate or too many variables 
that can affect the outcome of the test.  More prospective studies need to be performed 
examining all of the commonly used tests using better guidelines for a “positive” patient 
with H. pylori.   
17 
 
 
Table 1. Summary of Articles Reviewed 
 
 
 
 
 
Author/  Title/ 
Journal 
Yr.  
 
Patients/  
Population 
Intervention Comparison Outcome(s) Study 
type 
Validity 
(Jadad score) 
Xavier Calvet, Accuracy of 
Diagnostic Tests for 
Helicobactor pylori: A 
Reappraisal 
2009 199 dyspeptic 
patients 
UBT, stool test, 
biopsy based 
tests, RUT 
NONE Histological and 
RUT showed 
excellent 
diagnostic 
reliability, with 
stool>accuracy 
than UBT 
Prospective 1/5 
N. Pacheco, Comparison of 
PCT and common clinical 
test for the diagnosis of H. 
Pylori in dyspeptic patients 
2001 106 dyspeptic 
patients. Serum 
and gastric 
biopsy 
specimens 
were examined 
Tested dyspeptic 
patients with 
PCR, RUT, UBT 
Compared with 
PCR 
Indicates no 
advantage of 
using 
combination 
methods over 
RUT alone 
Prospective  
1/5 
Nishikawa, A prospective 
evaluation of new rapid 
urease tests before and after 
eradication treatment of 
Helicobacter pylori, in 
comparison with histology, 
culture, and 13 C Urea 
breath test 
 
 
 
2000 
 
 
 
278 total 
patients, 115 
before 
eradication and 
163 after.  
 
Eight biopsies 
taken from 
antrum and body 
of stomach for 
histology, culture 
and rapid urease 
tests. Also 
performed was 
13C urea breath 
test.  
 
 
 
Histology, 
culture and Urea 
breath test 
 
 
 
Both RUT test 
have equal 
sensitivity 
before treatment 
however, after 
treatment is was 
lower.  
 
 
Prospective 
 
 
 
 
 
 
1/5 
Thijs, Diagnostic Tests for 
Helicobacter pylori: A 
Prospective Evaluation of 
their Accuracy, without 
Selection a Single Test as 
the gold standard. 
1996 105 outpatients 
undergoing 
upper GI 
endoscopy 
Culture, PCR, 
histology, 
serology, rapid 
urease test and 
urea breath test 
NONE  Prospective 1/5 
NOTE: Jadad scores not 
valid due to the bases on 
RCT info such as 
randomization and double 
blind, difficult to find RCT 
when investigating a 
diagnostic clinical 
question. 
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